• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Office Procedures Warning

Article

Any procedures described on ConsultantLive.com should not be performed by clinicians without appropriate and complete training, evaluation of their patient’s condition and any possible contraindications or risk factors, review of any applicable manufacturer’s product information, and comparison with the recommendations of other authorities.

Any procedures described on ConsultantLive.com should not be performed by clinicians without appropriate and complete training, evaluation of their patient’s condition and any possible contraindications or risk factors, review of any applicable manufacturer’s product information, and comparison with the recommendations of other authorities.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Approves Second Generic OTC Naloxone Nasal Spray to Reverse Opioid Overdose / image credit Narcan ©Waldenmarus/stock.adobe.com

FDA Approves Second Generic OTC Naloxone Nasal Spray to Reverse Opioid Overdose

April 26th 2024
Article

The newest generic OTC nonprescription naloxone hydrochloride nasal spray provides additional access to the lifesaving treatment, at potentially lower cost.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight / image credit ©brovarky/stock.adobe.com

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight

April 25th 2024
Article

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI in Women / image credit fda approval ©Walenmarus/stock.adobe.com

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI

April 25th 2024
Article

Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.

Food vs Medicine for IBS: Dietary Measures First, New Study Suggests / image credit IBS ©Yurii Kibalnik/stock.adobe.com

Food vs Medicine for IBS: Dietary Measures First, New Study Suggests

April 25th 2024
Article

More participants consuming either of 2 common IBS dietary regimens experienced significant and sustained symptom relief vs those given pharmacotherapy.

© 2024 MJH Life Sciences

All rights reserved.